June 30, 2022
With the FDA ordering Juul to stop selling their e-cigarette devices, UNC School of Medicine researchers led by Ilona Jaspers, PhD, published the first study to compare the respiratory immune health effects of different types of devices.
April 29, 2022
James S. Hagood, MD, professor in the UNC Department of Pediatrics and Director of the Program for Rare and Interstitial Lung Disease of the UNC Children’s Research Institute and Marsico Lung Institute, has been selected as a Harrington Scholar-Innovator for his work on a therapeutic Strategy for pulmonary fibrosis.
April 5, 2022
Researchers at the University of North Carolina at Chapel Hill and the UNC Lineberger Comprehensive Cancer Center have uncovered a new checkpoint that cells use to control what molecules they internalize. Understanding the determinants for entry into cells could lead to the design of better therapeutics that must enter through this gatekeeping mechanism.
March 1, 2022
The Translational Team Science Awards program is aimed at capitalizing on UNC-Chapel Hill’s culture of collaboration and fostering interdisciplinary teams of basic science and clinical investigators.
January 31, 2022
The UNC Center for Environmental Medicine, Asthma, and Lung Biology, led by Ilona Jaspers, PhD, was awarded an EPA cooperative agreement for $4.5 million over three years.
December 15, 2021
The Eshelman Institute for Innovation recently opened its pre-proposal application for the 2022 annual grant cycle. The Institute seeks to fund translational research related to therapeutics focused on oncology, infectious disease, and neuroscience, including rare diseases, and all digital health technologies. The Institute also welcomes ideas for devices and diagnostics, and other therapeutic areas and services.
November 8, 2021
Jim Hagood, MD, Professor of Pediatrics, and Ronit Freeman, PhD, Associate Professor in Applied Physical Science, have been awarded a grant by Eshelman Institute for Innovation to pursue research in lung fibrosis.
September 22, 2021
The UNC School of Medicine lab of Mehmet Kesimer, PhD, has further illuminated the molecular intricacies of mucus and its role in pulmonary diseases, laying more groundwork for better therapies for chronic obstructive pulmonary disease and other airway conditions. The findings are published in the Proceedings of the National Academy of Sciences.
September 1, 2021
Register for our annual IHQI Symposium to celebrate the hard work and success of our Improvement Scholars. The Symposium will feature presentations from six clinician-led improvement initiatives.
February 3, 2021
Meghan E. Rebuli, PhD, Assistant Professor of Pediatrics, and her team with the Center for Environmental Medicine, Asthma and Lung Biology, had their publication, "Electronic-cigarette use alters nasal mucosal immune response to live-attenuated influenza virus. A clinical trial." named Extramural Paper of the Month for February 2021 by the NIEHS Environmental Factor.
October 15, 2020
NC State and UNC School of Medicine researchers, co-led by Tom Egan, MD, developed a technique to provide non-invasive assessments of lung conditions.
September 17, 2020
The trade magazine Pulmonology Consultant asked Mehmet Kesimer, PhD, four important questions about mucin abnormalities in early COPD.